DOMINIC MORGILLO: Open Payments
NPI 1285498469 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,128 in 137 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $933 · 2025 $2,128
Food & beverage: $2,128
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $222 |
| Alkermes, Inc. | 16 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $194 |
| Otsuka America Pharmaceutical, Inc. | 18 | $177 |
| ABBVIE INC. | 12 | $177 |
| Janssen Pharmaceuticals, Inc | 10 | $171 |
| Teva Pharmaceuticals USA, Inc. | 12 | $162 |
| Supernus Pharmaceuticals, Inc. | 6 | $112 |
| Axsome Therapeutics, Inc. | 4 | $96 |
| Vanda Pharmaceuticals Inc. | 5 | $95 |
Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, ARISTADA, Qelbree, AUSTEDO XR, SPRAVATO.
Industry payments across OH — which companies pay providers there.
